MIR1972-2

Across TCGA pan-cancer cohorts, MIR1972-2 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of MIR1972-2’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR1972-2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR1972-2 is over-expressed in tumor, although a few such as LUSC and PAAD show the opposite, repressed pattern.

STAD, LUSC, and UCEC are the cancer types where MIR1972-2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR1972-2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	All	+0.860	.002	4	view →
LUSC	Female	All	−0.345	.010	3	view →
UCEC	All	IV	+1.260	.019	2	view →
PAAD	Male	All	−0.935	.004	2	view →
KIRP	Male	All	−0.222	.012	2	view →
KIRC	Male	IV	−0.209	.041	2	view →
LUAD	All	All	+0.293	.027	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

MIR1972-2–STAD

Open the STAD breakdown →